Sanjay Shukla is President and Chief Executive Officer of aTYR PHARMA INC (ATYR). The company reported total compensation of $3,456,253 for fiscal year 2025.
| Salary | $638,977 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $2,595,200 |
| Non-equity incentive plan | $210,862 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $11,214 |
| Total | $3,456,253 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure aTYR PHARMA INC filed March 26, 2026, accession 0001339970-26-000021.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President and Chief Executive Officer | $638,977 | $0 | $0 | $2,595,200 | $210,862 | $0 | $11,214 | $3,456,253 |
| FY2024 | President and Chief Executive Officer | $580,887 | $0 | $0 | $641,760 | $246,877 | $0 | $10,998 | $1,480,522 |
Totals as disclosed in each year's own compensation disclosure for aTYR PHARMA INC.
| Peer-group chief executive median | $5,094,999 |
|---|---|
| Difference from that median | $-1,638,746 |
| Percentile within the disclosed peer group | 33rd |
| Peers with a disclosed figure | 7 |
Medians and percentiles are computed across the peer group aTYR PHARMA INC discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Sanjay Shukla this page | President and Chief Executive Officer | $3,456,253 |
| Jill Broadfoot | Chief Financial Officer | $1,309,913 |
| Nancy Denyes | General Counsel and Corporate Secretary | $1,284,841 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full aTYR PHARMA INC compensation brief.
Sanjay Shukla's compensation sits inside aTYR PHARMA INC's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.